Joglekar Pathology Consultancy Limited 10277834 false 2024-08-01 2025-07-31 2025-07-31 The principal activity of the company is Pathology consultants Digita Accounts Production Advanced 6.30.9574.0 true 10277834 2024-08-01 2025-07-31 10277834 2025-07-31 10277834 core:CurrentFinancialInstruments core:WithinOneYear 2025-07-31 10277834 bus:Micro-entities 2024-08-01 2025-07-31 10277834 bus:AuditExemptWithAccountantsReport 2024-08-01 2025-07-31 10277834 bus:FullAccounts 2024-08-01 2025-07-31 10277834 bus:SmallCompaniesRegimeForAccounts 2024-08-01 2025-07-31 10277834 bus:RegisteredOffice 2024-08-01 2025-07-31 10277834 bus:Director1 2024-08-01 2025-07-31 10277834 bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 10277834 countries:EnglandWales 2024-08-01 2025-07-31 10277834 2023-08-01 2024-07-31 10277834 2024-07-31 10277834 core:CurrentFinancialInstruments core:WithinOneYear 2024-07-31 iso4217:GBP xbrli:pure

Registration number: 10277834

Joglekar Pathology Consultancy Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 July 2025

 

Joglekar Pathology Consultancy Limited

(Registration number: 10277834)
Balance Sheet as at 31 July 2025

2025
£

2024
£

Current assets

279,830

153,286

Creditors: Amounts falling due within one year

(46,332)

(9,002)

 

233,498

144,284

Capital and reserves

233,498

144,284

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
The Old Dairy
Ashton Hill Farm Weston Road
Failand
Bristol
Avon
BS8 3UZ
United Kingdom

These financial statements were authorised for issue by the director on 19 September 2025.

1.1

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2024 - 1).

For the financial year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and FRS 105 ‘The Financial Reporting Standard Applicable to the Micro-entities Regime.

Approved and authorised by the director on 19 September 2025
 

.........................................
Dr Jayshree Ashwinikumar Pawade
Director